GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (BOM:524470) » Definitions » EBITDA Margin %

Syncom Formulation (India) (BOM:524470) EBITDA Margin % : 15.94% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Syncom Formulation (India) EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Syncom Formulation (India)'s EBITDA for the three months ended in Sep. 2024 was ₹163 Mil. Syncom Formulation (India)'s Revenue for the three months ended in Sep. 2024 was ₹1,023 Mil. Therefore, Syncom Formulation (India)'s EBITDA margin for the quarter that ended in Sep. 2024 was 15.94%.


Syncom Formulation (India) EBITDA Margin % Historical Data

The historical data trend for Syncom Formulation (India)'s EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) EBITDA Margin % Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.94 18.78 14.67 15.42 16.60

Syncom Formulation (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.30 18.25 17.61 13.51 15.94

Competitive Comparison of Syncom Formulation (India)'s EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s EBITDA Margin % falls into.



Syncom Formulation (India) EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Syncom Formulation (India)'s EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=430.311/2592.44
=16.60 %

Syncom Formulation (India)'s EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=163.103/1023.142
=15.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India)  (BOM:524470) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Syncom Formulation (India) EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) Headlines

No Headlines